Antiretroviral therapy coverage in Senegal
Senegal: Antiretroviral therapy coverage was 79.0% in 2024. ◆ Volatile
Antiretroviral therapy coverage in Senegal, 2000–2024
Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of people living with HIV.
Analysis
In 2024, antiretroviral therapy coverage in Senegal stood at 79.0%. That is the highest value across all 25 years on record.
The figure is up 2.6% on the previous year and up 97.5% over ten years.
Over the whole period, antiretroviral therapy coverage in Senegal peaked at 79.0% in 2024 and was at its lowest, 0.0%, in 2000.
That places Senegal 53rd out of 143 countries with data for 2024, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Antiretroviral therapy coverage in Senegal, year by year
| Year | % of people living with HIV | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 0.0% | — |
| 2006 | 1.0% | — |
| 2007 | 18.0% | +1700.0% |
| 2008 | 21.0% | +16.7% |
| 2009 | 25.0% | +19.0% |
| 2010 | 28.0% | +12.0% |
| 2011 | 31.0% | +10.7% |
| 2012 | 29.0% | -6.5% |
| 2013 | 33.0% | +13.8% |
| 2014 | 40.0% | +21.2% |
| 2015 | 46.0% | +15.0% |
| 2016 | 53.0% | +15.2% |
| 2017 | 58.0% | +9.4% |
| 2018 | 66.0% | +13.8% |
| 2019 | 71.0% | +7.6% |
| 2020 | 74.0% | +4.2% |
| 2021 | 75.0% | +1.4% |
| 2022 | 76.0% | +1.3% |
| 2023 | 77.0% | +1.3% |
| 2024 | 79.0% | +2.6% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 6.5% | 0.0% | 25.0% | 10 |
| 2010s | 45.5% | 28.0% | 71.0% | 10 |
| 2020s | 76.2% | 74.0% | 79.0% | 5 |
Countries ranked near Senegal
- 51 Cape Verde 80.0% compare
- 51 Peru 80.0% compare
- 53 Argentina 79.0% compare
- 53 Guinea-Bissau 79.0% compare
- 53 Lebanon 79.0% compare
More health data for Senegal
- Un projection of annual infant deaths, annual growth rate -1.58 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.7598 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 835.5 deaths per 1,000 people (2090)
- Number of infants who die before age 1 2,496 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 3 (2025)
- Population ages 00-04, female, annual growth rate 2.42 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0658 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.29 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is antiretroviral therapy coverage in Senegal?
- Antiretroviral therapy coverage in Senegal was 79.0% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
- What is the highest antiretroviral therapy coverage recorded in Senegal?
- The highest recorded value was 79.0% in 2024.
- What is the lowest antiretroviral therapy coverage recorded in Senegal?
- The lowest recorded value was 0.0% in 2000.
- How does Senegal rank for antiretroviral therapy coverage?
- Senegal ranks 53rd out of 143 countries with data for 2024.
- Is antiretroviral therapy coverage rising or falling in Senegal?
- Over the last ten years it is up 97.5%. The long-run trend across the full record is volatile.
- Where does this Senegal data come from?
- The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage (% of people living with HIV). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.